Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

Melissa Pilewskie, Michelle Stempel, Hope Rosenfeld, Anne Eaton, Kimberly J. Van Zee, Monica Morrow

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Fingerprint

Dive into the research topics of 'Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?'. Together they form a unique fingerprint.

Medicine & Life Sciences